Cost-Effectiveness Analysis of Ixekizumab vs. Secukinumab in Sequential Biologic Treatment of Psoriasis in the UK
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1279
https://www.valueinhealthjournal.com/article/S1098-3015(16)32645-6/fulltext
Title :
Cost-Effectiveness Analysis of Ixekizumab vs. Secukinumab in Sequential Biologic Treatment of Psoriasis in the UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32645-6&doi=10.1016/j.jval.2016.09.1279
First page :
A568
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1200